Checkpoint inhibitor‐induced bullous pemphigoid differs from spontaneous bullous pemphigoid
Nora Kramer, G. Müller, Sarah Zierold, Magdalena Röckel, Waltraud Fröhlich, Matthias Schefzyk, Jörg Kumbrink, Jessica C. Hassel, Carola Berking, Mirjana Ziemer, D. Nashan, Lars E. French, Julio Vera, K. Kerl-French, Ralf Gutzmer, Lucie Heinzerling
Abstract
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Topics & Concepts
Bullous pemphigoidDermatologyMedicinePemphigoidImmunologyAntibodyAutoimmune Bullous Skin DiseasesCoagulation, Bradykinin, Polyphosphates, and AngioedemaPlatelet Disorders and Treatments